ES424362A1 - Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente. - Google Patents

Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente.

Info

Publication number
ES424362A1
ES424362A1 ES424362A ES424362A ES424362A1 ES 424362 A1 ES424362 A1 ES 424362A1 ES 424362 A ES424362 A ES 424362A ES 424362 A ES424362 A ES 424362A ES 424362 A1 ES424362 A1 ES 424362A1
Authority
ES
Spain
Prior art keywords
stabilizing
ophthalmic formulation
topical ophthalmic
active compound
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES424362A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nelson Research and Development Co
Original Assignee
Nelson Research and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00341732A external-priority patent/US3824313A/en
Application filed by Nelson Research and Development Co filed Critical Nelson Research and Development Co
Publication of ES424362A1 publication Critical patent/ES424362A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
ES424362A 1973-03-16 1974-03-16 Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente. Expired ES424362A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00341732A US3824313A (en) 1973-03-16 1973-03-16 Topical opthalmic composition and methods of use
US44568574A 1974-02-25 1974-02-25

Publications (1)

Publication Number Publication Date
ES424362A1 true ES424362A1 (es) 1976-10-16

Family

ID=26992634

Family Applications (1)

Application Number Title Priority Date Filing Date
ES424362A Expired ES424362A1 (es) 1973-03-16 1974-03-16 Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente.

Country Status (7)

Country Link
JP (1) JPS5833202B2 (OSRAM)
CA (1) CA1024070A (OSRAM)
DE (1) DE2411019C2 (OSRAM)
DK (1) DK136884B (OSRAM)
ES (1) ES424362A1 (OSRAM)
FR (1) FR2221140B1 (OSRAM)
GB (1) GB1459264A (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6049087B2 (ja) 2010-09-30 2016-12-21 ソルヴェイ（ソシエテ アノニム） 天然起源のエピクロロヒドリンの誘導体
EP3860600A4 (en) * 2018-10-06 2022-07-20 Biotheravision, Inc OPHTHALMIC PREPARATIONS OF MUSCARINIC AGONIST AND METHODS OF USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300422B (OSRAM) * 1964-07-03 1968-04-29 Astra Ab

Also Published As

Publication number Publication date
DE2411019C2 (de) 1986-11-20
AU6679074A (en) 1975-09-18
JPS5833202B2 (ja) 1983-07-18
FR2221140B1 (OSRAM) 1977-07-01
FR2221140A1 (OSRAM) 1974-10-11
JPS5035320A (OSRAM) 1975-04-04
DE2411019A1 (de) 1974-09-26
GB1459264A (en) 1976-12-22
CA1024070A (en) 1978-01-10
DK136884B (da) 1977-12-12

Similar Documents

Publication Publication Date Title
IE45256L (en) Quinazolone derivatives
HU170778B (hu) Fungicidnye kompozicii i sposob poluchenija proizvodnykh l-propil-imidazola i soli, to est' soedinenijj primenimykh aktivnymi agentami
GB1335783A (en) Anti-seborrhoeic compositions
GB1142066A (en) New diphenyl-ureas and process for preparing them
SE7411243L (OSRAM)
ES400452A1 (es) Procedimiento para la obtencion de un medio para regular el crecimiento de las plantas a base de acidos 2-halogenoe- tano sulfinicos.
ES368955A1 (es) Procedimiento para preparar guanidinas sustituidas
GB1362845A (en) Benzyl alcohol derivatives
IE800179L (en) Pharmaceutical compositions containing paracetamol.
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
GB1529251A (en) 9,10-dihydroergopeptines
ES395433A1 (es) Procedimiento para la estabilizacion de una solucion acuosainyectable.
SE7513126L (sv) Nya kvevehaltiga, polycykliska foreningar jemte sett for deras framstellning
ES391536A1 (es) Procedimiento para la obtencion de composiciones antibacte-riales.
ES382438A1 (es) Un procedimiento para la preparacion de una composicion farmaceutica para reducir la irritacion gastrica.
GB1319402A (en) 3-acyloxypropyl-2,-trimethylammoniumethyl phosphates
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
GB1437788A (en) Therapeutic compositions
GB1332635A (en) Rutin complexes
ES369646A1 (es) Un procedimiento de preparacion de los derivados de acido 5-tiazol carboxilico.
ES390754A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazoloquinolina.
GB1459264A (en) Method of stabilizing a topical ophthalmic formulation
ES400624A1 (es) Procedimiento para la preparacion de derivados de acido pe-niciloico.
ES294928A1 (es) Un procedimiento de preparar una composición líquida y estable de tetraciclina
GB1297595A (OSRAM)